Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer

References

• Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005; 23:337-66; PMID:15771574; https://doi.org/10.1146/annurev.immunol.23.021704.115756
   PubMed Web of Science ®Google Scholar
• Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: Pentraxins as a paradigm. Annu Rev Immunol 2010; 28:157-83; PMID:19968561; https://doi.org/10.1146/annurev-immunol-030409-101305
   PubMed Web of Science ®Google Scholar
• Deban L, Russo RC, Sironi M, Moalli F, Scanziani M, Zambelli V, Cuccovillo I, Bastone A, Gobbi M, Valentino S et al. Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol 2010; 11:328-34; PMID:20208538; https://doi.org/10.1038/ni.1854
   PubMed Web of Science ®Google Scholar
• Doni A, Musso T, Morone D, Bastone A, Zambelli V, Sironi M, Castagnoli C, Cambieri I, Stravalaci M, Pasqualini F et al. An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode. J Exp Med 2015; 212:905-25; PMID:25964372; https://doi.org/10.1084/jem.20141268
   PubMed Web of Science ®Google Scholar
• Jaillon S, Moalli F, Ragnarsdottir B, Bonavita E, Puthia M, Riva F, Barbati E, Nebuloni M, Cvetko Krajinovic L, Markotic A et al. The humoral pattern recognition molecule PTX3 is a key component of innate immunity against urinary tract infection. Immunity 2014; 40:621-32; PMID:24745336; https://doi.org/10.1016/j.immuni.2014.02.015
   PubMed Web of Science ®Google Scholar
• Jaillon S, Peri G, Delneste Y, Fremaux I, Doni A, Moalli F, Garlanda C, Romani L, Gascan H, Bellocchio S et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007; 204:793-804; PMID:17389238; https://doi.org/10.1084/jem.20061301
   PubMed Web of Science ®Google Scholar
• Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, Vago L, Pasqualini F, Signorini S, Soldateschi D et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004; 110:2349-54; PMID:15477419; https://doi.org/10.1161/01.CIR.0000145167.30987.2E
   PubMed Web of Science ®Google Scholar
• Bonavita E, Gentile S, Rubino M, Maina V, Papait R, Kunderfranco P, Greco C, Feruglio F, Molgora M, Laface I et al. PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer. Cell 2015; 160:700-14; PMID:25679762; https://doi.org/10.1016/j.cell.2015.01.004
   PubMed Web of Science ®Google Scholar
• Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci U S A 2010; 107:21931-6; PMID:21106759; https://doi.org/10.1073/pnas.1016071107
   PubMed Web of Science ®Google Scholar
• Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, Stuart RK, Ching CW et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009; 459:108-12; PMID:19295514; https://doi.org/10.1038/nature07829
   PubMed Web of Science ®Google Scholar
• Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011; 470:279-83; PMID:21160473; https://doi.org/10.1038/nature09692
   PubMed Web of Science ®Google Scholar
• Stergachis AB, Haugen E, Shafer A, Fu W, Vernot B, Reynolds A, Raubitschek A, Ziegler S, LeProust EM, Akey JM et al. Exonic transcription factor binding directs codon choice and affects protein evolution. Science 2013; 342:1367-72; PMID:24337295; https://doi.org/10.1126/science.1243490
   PubMed Web of Science ®Google Scholar
• Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, Wright C, Chen F et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 2009; 457:854-8; PMID:19212405; https://doi.org/10.1038/nature07730
   PubMed Web of Science ®Google Scholar
• Visel A, Rubin EM, Pennacchio LA. Genomic views of distant-acting enhancers. Nature 2009; 461:199-205; PMID:19741700; https://doi.org/10.1038/nature08451
   PubMed Web of Science ®Google Scholar
• Lavin Y, Winter D, Blecher-Gonen R, David E, Keren-Shaul H, Merad M, Jung S, Amit I. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 2014; 159:1312-26; PMID:25480296; https://doi.org/10.1016/j.cell.2014.11.018
   PubMed Web of Science ®Google Scholar
• Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann NJ, Stender JD, Chun HB, Garner H, Geissmann F et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 2014; 159:1327-40; PMID:25480297; https://doi.org/10.1016/j.cell.2014.11.023
   PubMed Web of Science ®Google Scholar
• Vahedi G, Takahashi H, Nakayamada S, Sun HW, Sartorelli V, Kanno Y, O'Shea JJ. STATs shape the active enhancer landscape of T cell populations. Cell 2012; 151:981-93; PMID:23178119; https://doi.org/10.1016/j.cell.2012.09.044
   PubMed Web of Science ®Google Scholar
• Akhtar-Zaidi B, Cowper-Sal-lari R, Corradin O, Saiakhova A, Bartels CF, Balasubramanian D, Myeroff L, Lutterbaugh J, Jarrar A, Kalady MF et al. Epigenomic enhancer profiling defines a signature of colon cancer. Science 2012; 336:736-9; PMID:22499810; https://doi.org/10.1126/science.1217277
   PubMed Web of Science ®Google Scholar
• McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, Bejerano G. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 2010; 28:495-501; PMID:20436461; https://doi.org/10.1038/nbt.1630
   PubMed Web of Science ®Google Scholar
• Doni A, Michela M, Bottazzi B, Peri G, Valentino S, Polentarutti N, Garlanda C, Mantovani A. Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: Stimulation by IL-10 and inhibition by IFN-gamma. J Leukoc Biol 2006; 79:797-802; PMID:16461742; https://doi.org/10.1189/jlb.0905493
   PubMed Web of Science ®Google Scholar
• Zentner GE, Tesar PJ, Scacheri PC. Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. Genome Res 2011; 21:1273-83; PMID:21632746; https://doi.org/10.1101/gr.122382.111
   PubMed Web of Science ®Google Scholar
• Basile A, Sica A, d'Aniello E, Breviario F, Garrido G, Castellano M, Mantovani A, Introna M. Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation. J Biol Chem 1997; 272:8172-8; PMID:9079634; https://doi.org/10.1074/jbc.272.13.8172
   PubMed Web of Science ®Google Scholar
• Altmeyer A, Klampfer L, Goodman AR, Vilcek J. Promoter structure and transcriptional activation of the murine TSG-14 gene encoding a tumor necrosis factor/interleukin-1-inducible pentraxin protein. J Biol Chem 1995; 270:25584-90; PMID:7592730; https://doi.org/10.1074/jbc.270.43.25584
   PubMed Web of Science ®Google Scholar
• Spitz F, Furlong EE. Transcription factors: From enhancer binding to developmental control. Nat Rev Genet 2012; 13:613-26; PMID:22868264; https://doi.org/10.1038/nrg3207
   PubMed Web of Science ®Google Scholar
• Vernimmen D, De Gobbi M, Sloane-Stanley JA, Wood WG, Higgs DR. Long-range chromosomal interactions regulate the timing of the transition between poised and active gene expression. EMBO J 2007; 26:2041-51; PMID:17380126; https://doi.org/10.1038/sj.emboj.7601654
   PubMed Web of Science ®Google Scholar
• Savic D, Roberts BS, Carleton JB, Partridge EC, White MA, Cohen BA, Cooper GM, Gertz J, Myers RM. Promoter-distal RNA polymerase II binding discriminates active from inactive CCAAT/ enhancer-binding protein beta binding sites. Genome Res 2015; 25:1791-800; PMID:26486725; https://doi.org/10.1101/gr.191593.115
   PubMed Web of Science ®Google Scholar
• Simon JA, Kingston RE. Mechanisms of polycomb gene silencing: Knowns and unknowns. Nat Rev Mol Cell Biol 2009; 10:697-708; PMID:19738629; https://doi.org/10.1038/nrm2763
   PubMed Web of Science ®Google Scholar
• De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 2007; 130:1083-94; PMID:17825402; https://doi.org/10.1016/j.cell.2007.08.019
   PubMed Web of Science ®Google Scholar
• Tripathy MK, McManamy ME, Burch BD, Archin NM, Margolis DM. H3K27 demethylation at the proviral promoter sensitizes latent HIV to the effects of vorinostat in ex vivo cultures of resting CD4+ T Cells. J Virol 2015; 89:8392-405; PMID:26041287; https://doi.org/10.1128/JVI.00572-15
   PubMed Web of Science ®Google Scholar
• Ding M, Zhang H, Li Z, Wang C, Chen J, Shi L, Xu D, Gao Y. The polycomb group protein enhancer of zeste 2 is a novel therapeutic target for cervical cancer. Clin Exp Pharmacol Physiol 2015; 42:458-64; PMID:25739318; https://doi.org/10.1111/1440-1681.12382
   PubMed Web of Science ®Google Scholar
• Cunha C, Aversa F, Lacerda JF, Busca A, Kurzai O, Grube M, Löffler J, Maertens JA, Bell AS, Inforzato A et al. Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. N Engl J Med 2014; 370:421-32; PMID:24476432; https://doi.org/10.1056/NEJMoa1211161
   PubMed Web of Science ®Google Scholar
• Barbati E, Specchia C, Villella M, Rossi ML, Barlera S, Bottazzi B, Crociati L, d'Arienzo C, Fanelli R, Garlanda C et al. Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels. PLoS One 2012; 7:e53030; PMID:23285251; https://doi.org/10.1371/journal.pone.0053030
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang HY, Woetmann A, Raghunath PN, Odum N, Wasik MA. STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood 2006; 108:1058-64; PMID:16861352; https://doi.org/10.1182/blood-2005-08-007377
   PubMed Web of Science ®Google Scholar
• Yu H, Lee H, Herrmann A, Buettner R, Jove R. Revisiting STAT3 signalling in cancer: New and unexpected biological functions. Nat Rev Cancer 2014; 14:736-46; PMID:25342631; https://doi.org/10.1038/nrc3818
   PubMed Web of Science ®Google Scholar
• Kang HJ, Yi YW, Hou SJ, Kim HJ, Kong Y, Bae I, Brown ML. Disruption of STAT3-DNMT1 interaction by SH-I-14 induces re-expression of tumor suppressor genes and inhibits growth of triple-negative breast tumor. Oncotarget 2015; PMID:26675255; https://doi.org/10.18632/oncotarget.4054
   PubMedGoogle Scholar
• Schust J, Sperl B, Hollis A, Mayer TU, Berg T. Stattic: A small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 2006; 13:1235-42; PMID:17114005; https://doi.org/10.1016/j.chembiol.2006.09.018
   PubMed Web of Science ®Google Scholar
• Pan Y, Zhou F, Zhang R, Claret FX. Stat3 inhibitor stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma. PLoS One 2013; 8:e54565; PMID:23382914; https://doi.org/10.1371/journal.pone.0054565
   PubMed Web of Science ®Google Scholar
• Jaillon S, Bonavita E, Gentile S, Rubino M, Laface I, Garlanda C, Mantovani A. The long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases. Int Arch Allergy Immunol 2014; 165:165-78; PMID:25531094; https://doi.org/10.1159/000368778
   PubMed Web of Science ®Google Scholar
• Koch F, Fenouil R, Gut M, Cauchy P, Albert TK, Zacarias-Cabeza J, Spicuglia S, de la Chapelle AL, Heidemann M, Hintermair C et al. Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nat Struct Mol Biol 2011; 18:956-63; PMID:21765417; https://doi.org/10.1038/nsmb.2085
   PubMed Web of Science ®Google Scholar
• Sawarkar R, Paro R. Interpretation of developmental signaling at chromatin: The polycomb perspective. Dev Cell 2010; 19:651-61; PMID:21074716; https://doi.org/10.1016/j.devcel.2010.10.012
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang Q, Ding Y, Li X, Zhao D, Zhao K, Guo Z, Cao X. Histone lysine methyltransferase Ezh1 promotes TLR-triggered inflammatory cytokine production by suppressing Tollip. J Immunol 2015; 194:2838-46; PMID:25687760; https://doi.org/10.4049/jimmunol.1402087
   PubMed Web of Science ®Google Scholar
• Thomas NS. The STAT3-DNMT1 connection. JAKSTAT 2012; 1:257-60; PMID:24058781; https://doi.org/10.4161/jkst.22436
   PubMedGoogle Scholar
• Zhang Q, Wang HY, Marzec M, Raghunath PN, Nagasawa T, Wasik MA. STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci U S A 2005; 102:6948-53; PMID:15870198; https://doi.org/10.1073/pnas.0501959102
   PubMed Web of Science ®Google Scholar
• Olesen R, Wejse C, Velez DR, Bisseye C, Sodemann M, Aaby P, Rabna P, Worwui A, Chapman H, Diatta M et al. DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans. Genes Immun 2007; 8:456-67; PMID:17611589; https://doi.org/10.1038/sj.gene.6364410
   PubMed Web of Science ®Google Scholar
• Chiarini M, Sabelli C, Melotti P, Garlanda C, Savoldi G, Mazza C, Padoan R, Plebani A, Mantovani A, Notarangelo LD et al. PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients. Genes Immun 2010; 11:665-70; PMID:20927127; https://doi.org/10.1038/gene.2010.41
   PubMed Web of Science ®Google Scholar
• Matsumura K, Saito T, Takahashi Y, Ozeki T, Kiyotani K, Fujieda M, Yamazaki H, Kunitoh H, Kamataki T. Identification of a novel polymorphic enhancer of the human CYP3A4 gene. Mol Pharmacol 2004; 65:326-34; PMID:14742674; https://doi.org/10.1124/mol.65.2.326
   PubMed Web of Science ®Google Scholar
• Liu H, Zhai J, Luo K, Liu L. Chromatin structure is distinct between coding and non-coding single nucleotide polymorphisms. BMC Mol Biol 2014; 15:22; PMID:25282079; https://doi.org/10.1186/1471-2199-15-22
   PubMed Web of Science ®Google Scholar
• Inforzato A, Doni A, Barajon I, Leone R, Garlanda C, Bottazzi B, Mantovani A. PTX3 as a paradigm for the interaction of pentraxins with the complement system. Semin Immunol 2013; 25:79-85; PMID:23747040; https://doi.org/10.1016/j.smim.2013.05.002
   PubMed Web of Science ®Google Scholar
• Ovcharenko I, Nobrega MA, Loots GG, Stubbs L. ECR Browser: A tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res 2004; 32:W280-6; PMID:15215395; https://doi.org/10.1093/nar/gkh355
   PubMed Web of Science ®Google Scholar
• Papait R, Cattaneo P, Kunderfranco P, Greco C, Carullo P, Guffanti A, Viganò V, Stirparo GG, Latronico MV, Hasenfuss G et al. Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy. Proc Natl Acad Sci U S A 2013; 110:20164-9; PMID:24284169; https://doi.org/10.1073/pnas.1315155110
   PubMed Web of Science ®Google Scholar
• Fanelli M, Amatori S, Barozzi I, Minucci S. Chromatin immunoprecipitation and high-throughput sequencing from paraffin-embedded pathology tissue. Nat Protoc 2011; 6:1905-19; PMID:22082985; https://doi.org/10.1038/nprot.2011.406
   PubMed Web of Science ®Google Scholar